BIMI Holdings Inc. (BIMI)
- Previous Close
1.1500 - Open
1.2000 - Bid --
- Ask --
- Day's Range
1.1600 - 1.3012 - 52 Week Range
0.7700 - 4.1300 - Volume
40,881 - Avg. Volume
47,930 - Market Cap (intraday)
17.224M - Beta (5Y Monthly) 1.67
- PE Ratio (TTM)
-- - EPS (TTM)
-6.3900 - Earnings Date May 2, 2024 - May 6, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
BIMI Holdings Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People's Republic of China. The company also distributes varieties of products, including raw ingredients for pharmaceutical products, antibiotics, cardiovascular drugs, and anti-obesity medicines. In addition, it offers prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines, personal and family care products, medical devices, and miscellaneous items under the Lijiantang Pharmacy brand name. Further, the company provides medical services in the hospitals, as well as IT research and development services; and operates two private hospitals in China. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as BIMI International Medical Inc. and changed its name to BIMI Holdings Inc. in January 2024. BIMI Holdings Inc. was incorporated in 2000 and is headquartered in New York, New York.
usbimi.com296
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: BIMI
Performance Overview: BIMI
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BIMI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BIMI
Valuation Measures
Market Cap
17.22M
Enterprise Value
20.70M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.16
Price/Book (mrq)
1.98
Enterprise Value/Revenue
1.64
Enterprise Value/EBITDA
-2.25
Financial Highlights
Profitability and Income Statement
Profit Margin
-83.20%
Return on Assets (ttm)
-13.01%
Return on Equity (ttm)
-103.78%
Revenue (ttm)
12.63M
Net Income Avi to Common (ttm)
-10.52M
Diluted EPS (ttm)
-6.3900
Balance Sheet and Cash Flow
Total Cash (mrq)
994.13k
Total Debt/Equity (mrq)
49.25%
Levered Free Cash Flow (ttm)
-5.75M